Lin Ming-Qiang, Wu Ya-Hua, Yang Jun, Lin Han-Cui, Liu Ling-Yun, Yu Yi-Lin, Yao Qi-Wei, Li Jian-Cheng
College of Clinical Medicine for Oncology, Fujian Medical University, Fuzhou, China.
Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.
Front Microbiol. 2022 Jun 9;13:883650. doi: 10.3389/fmicb.2022.883650. eCollection 2022.
Acute radiation-induced esophagitis (ARIE) is one of the most debilitating complications in patients who receive thoracic radiotherapy, especially those with esophageal cancer (EC). There is little known about the impact of the characteristics of gut microbiota on the initiation and severity of ARIE.
Gut microbiota samples of EC patients undergoing radiotherapy ( = 7) or concurrent chemoradiotherapy ( = 42) were collected at the start, middle, and end of the radiotherapy regimen. Assessment of patient-reported ARIE was also performed. Based on 16S rRNA gene sequencing, changes of the gut microbial community during the treatment regimen and correlations of the gut microbiota characteristics with the severity of ARIE were investigated.
There were significant associations of several properties of the gut microbiota with the severity of ARIE. The relative abundance of several genera in the phylum Proteobacteria increased significantly as mucositis severity increased. The predominant genera had characteristic changes during the treatment regimen, such as an increase of opportunistic pathogenic bacteria including . Patients with severe ARIE had significantly lower alpha diversity and a higher abundance of before radiotherapy, but patients with mild ARIE were enriched in , , , , , and . A model combining these genera had the best performance in prediction of severe ARIE (area under the curve: 0.907).
The characteristics of gut microbiota before radiotherapy were associated with subsequent ARIE severity. Microbiota-based strategies have potential use for the early prediction of subsequent ARIE and for the selection of interventions that may prevent severe ARIE.
急性放射性食管炎(ARIE)是接受胸部放疗患者中最使人衰弱的并发症之一,尤其是食管癌(EC)患者。关于肠道微生物群特征对ARIE发生及严重程度的影响,目前所知甚少。
在放疗方案开始、中期和结束时,收集接受放疗(n = 7)或同步放化疗(n = 42)的EC患者的肠道微生物群样本。同时进行患者报告的ARIE评估。基于16S rRNA基因测序,研究治疗方案期间肠道微生物群落的变化以及肠道微生物群特征与ARIE严重程度的相关性。
肠道微生物群的几个特性与ARIE的严重程度存在显著关联。随着粘膜炎严重程度增加,变形菌门中几个属的相对丰度显著增加。在治疗方案期间,优势菌属有特征性变化,如包括[具体菌名未给出]在内的机会致病菌增加。重度ARIE患者放疗前的α多样性显著较低,[具体菌名未给出]丰度较高,但轻度ARIE患者中[具体菌名未给出]、[具体菌名未给出]、[具体菌名未给出]、[具体菌名未给出]、[具体菌名未给出]和[具体菌名未给出]富集。结合这些菌属的模型在预测重度ARIE方面表现最佳(曲线下面积:0.907)。
放疗前肠道微生物群的特征与随后的ARIE严重程度相关。基于微生物群的策略在早期预测随后的ARIE以及选择可能预防重度ARIE的干预措施方面具有潜在用途。